The abortifacient effects of a newly developed vaginal silastic device impregnated with an 0.5% concentration of 15(s)-15-methyl-prostaglandin F2α methyl ester in the first trimester
- 1 June 1976
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 13 (6) , 697-705
- https://doi.org/10.1016/0010-7824(76)90121-9
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Luteolytic and abortifacient effects of serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2α in early pregnancyAmerican Journal of Obstetrics and Gynecology, 1976
- Termination of midtrimester pregnancy by serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2αAmerican Journal of Obstetrics and Gynecology, 1976
- Reduction of cervical resistance by prostaglandin suppositories prior to dilatation for induced abortionAmerican Journal of Obstetrics and Gynecology, 1975
- Midtrimester abortion induced by serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2αAmerican Journal of Obstetrics and Gynecology, 1975
- Induction of midtrimester abortion by serial intravaginal administration of 15(S)-15-methyl-prostaglandin F2α (THAM) suppositoriesProstaglandins, 1975
- Serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2α in the induction of abortionProstaglandins, 1975
- Reassessment of systemic administration of prostaglandins for induction of midtrimester abortionProstaglandins, 1974
- Response of the midpregnant human uterus to systemic administration of 15(S)-15-methyl-prostaglandin F2αProstaglandins, 1972
- NOVEL PROSTAGLANDIN SYNTHESESAnnals of the New York Academy of Sciences, 1971